View Mode:
JS
Data Source Integration Status
ClinicalTrials.gov
Updated 5m ago
12 new trials added today
3 status updates processed
PubMed
Updated 20m ago
8 new publications indexed
2 high-impact papers identified
FDA
Updated 1h ago
1 new approval announced
2 advisory committee meetings scheduled
Pipeline Tracker
Customize Columns
Pipeline Assets
Sort by:
| Asset | Company | Therapeutic Area | MOA | Phase | Trial Start Date | Primary Completion Date | Last Update | Actions |
|---|---|---|---|---|---|---|---|---|
|
PF-06939926
fordadistrogene movaparvovec
ClinicalTrials.gov
|
Pfizer
|
Rare Disease
Duchenne muscular dystrophy
|
Gene therapy
|
Phase 3 | Mar 15, 2023 | Dec 31, 2025 | 2h ago | View Details |
|
Kesimpta
ofatumumab
FDA
Press Release
|
Novartis
|
Neurology
Multiple sclerosis
|
Anti-CD20 mAb
|
Approved | Aug 30, 2020 | Completed | 1d ago | View Details |
|
MK-7189
nemtabrutinib
ClinicalTrials.gov
|
Merck
|
Oncology
Non-small cell lung cancer
|
BTK inhibitor
|
Phase 3 | Jan 10, 2024 | Sep 30, 2026 | 10m ago | View Details |
|
Rinvoq
upadacitinib
FDA
|
AbbVie
|
Immunology
Atopic dermatitis
|
JAK inhibitor
|
Filed | Jun 5, 2022 | Apr 15, 2024 | 3d ago | View Details |
|
REGN5458
linvoseltamab
ClinicalTrials.gov
Press Release
|
Regeneron
|
Oncology
Multiple myeloma
|
Bispecific antibody
|
Phase 2 | Nov 12, 2023 | Mar 28, 2025 | 5d ago | View Details |
Showing 1 to 5 of 42 results